Asem Elfert

Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and Ribavirin

Jean‐François Rossignol, Asem Elfert, Yehia El–Gohary et al. · Gastroenterology · 2008 · 146 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis

Asem Elfert, Lobna Abo Ali, Samah Soliman et al. · European Journal of Gastroenterology & Hepatology · 2016 · 103 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Clinical trial: randomized, double‐blind, placebo‐controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4

Jean‐François Rossignol, Samir M. Kabil, Y. El-Gohary et al. · Alimentary Pharmacology & Therapeutics · 2008 · 78 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53

Aditya Arya, Asem Elfert, Timothy Devling et al. · British Journal of Cancer · 2010 · 75 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Randomized controlled study of endoscopic band ligation and argon plasma coagulation in the treatment of gastric antral and fundal vascular ectasia

Mohammed Elhendawy, Samah Mosaad, Walaa Alkhalawany et al. · United European Gastroenterology Journal · 2015 · 52 citations · Full text

Medicine, Hematology, Surgery +9